What is the recommended treatment for type II achalasia (pan‑esophageal pressurization)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Type 2 Achalasia with Pan-Esophageal Pressurization

For type II achalasia (pan-esophageal pressurization), pneumatic dilation, laparoscopic Heller myotomy (LHM), and peroral endoscopic myotomy (POEM) are all highly effective first-line options, with type II achalasia showing the best response rates among all achalasia subtypes across all treatment modalities. 1

Treatment Algorithm

First-Line Treatment Options (Choose Based on Local Expertise and Patient Preference)

1. Pneumatic Dilation (PD)

  • Start with 30 mm diameter balloon in the first session to minimize perforation risk 2
  • Perform second dilation 2-28 days later with 35 mm balloon 2
  • Consider third session with cautious use of 40 mm balloon if Eckardt score remains >3 2
  • Type II achalasia shows 90-95% success rates with PD - the highest among all subtypes 3
  • Effectiveness: 90% at 1 year, 86% at 2 years; up to one-third may need repeat dilation during 4-6 years follow-up 2
  • Can be performed under endoscopic or fluoroscopic guidance based on local expertise 2
  • Perforation rate should be <2% 2

2. Peroral Endoscopic Myotomy (POEM)

  • Type II achalasia shows 97% success rates with POEM 4
  • Requires 20-40 procedures for operator competence; should only be performed at high-volume centers 5, 1
  • Clinical success rate of 88.9% for type II achalasia, with only 2.2% requiring redo POEM 6
  • Short myotomy (versus standard 10 cm myotomy) shows comparable efficacy with less postoperative acid exposure (23.9% vs 43.8%) 7
  • Major caveat: High risk of post-procedure reflux esophagitis requiring indefinite PPI therapy 5, 1

3. Laparoscopic Heller Myotomy (LHM)

  • Type II achalasia shows 92% success rate with LHM 4
  • Equivalent 5-year outcomes compared to pneumatic dilation 5
  • POEM shows no superiority over LHM specifically for type II achalasia 4

Post-Treatment Management

Mandatory Considerations

  • Initiate PPI therapy after any intervention due to 10-40% rate of symptomatic GERD or ulcerative esophagitis 2
  • All patients require ongoing monitoring for GERD after treatment, particularly after POEM 1
  • Consider repeat dilation during follow-up to maintain symptom response (remission rates: 97% at 5 years, 93% at 10 years) 2

Key Clinical Pearls

Why Type II Achalasia Responds Best

Type II achalasia (pan-esophageal pressurization) consistently demonstrates the most favorable outcomes across all treatment modalities compared to types I and III 6, 4, 3. This is the most common presenting subtype and has the best prognosis.

Treatment Selection Factors

  • If POEM expertise available: Consider POEM as comparable option to LHM for type II achalasia 5, 1
  • If limited resources or expertise: Pneumatic dilation remains highly effective with 90% success rate for type II achalasia 3
  • Patient preference regarding reflux risk: PD may have lower reflux rates than POEM
  • Prior failed treatments: POEM can serve as salvage therapy 6

Critical Pitfalls to Avoid

  • Do not start with 35-40 mm balloon initially - begin at 30 mm to reduce perforation risk 2
  • Do not perform POEM without adequate operator experience (minimum 20-40 cases) 5, 1
  • Do not neglect PPI therapy post-procedure - reflux esophagitis is common and requires proactive management 2, 1
  • Do not assume single treatment suffices - up to one-third may need repeat interventions during long-term follow-up 2

Special Consideration: Focal Elevated Pressures

If type II achalasia demonstrates focal elevated pressures ≥70 mmHg within the pressurization band, this represents a distinct sub-group with spastic features that may require personalized approaches, though specific treatment modifications are not yet established 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.